看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯，血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
0 h8 x/ ~* Y1 ?, \# L3 w) u9 ~$ l x6 W0 k/ z0 Z5 }
" A G7 ~+ b. N7 p; w, X& iCurrently available feasibility data for possible combination strategies.
* l# U$ p) k! c8 e————————————————————————————————
' a$ _( c+ v! FCombination Feasibility according to preliminary data # n2 A0 l3 V2 c' x) j* m
—————————————————————————————————— \4 w/ d c/ f& g. F/ [6 y9 d
Bevacizumab + sorafenib Yes, reduced dose $ z( X, e% j1 A- O6 ?; z) f& c
Bevacizumab + sunitinib† No . N4 V: b) m! W7 ]! a
Bevacizumab + temsirolimus Yes : w h0 c) h, O: D4 v# ~' e0 [
Bevacizumab + everolimus Yes
$ ~( n6 j( j: k3 [: }' ~Sorafenib + sunitinib ? ; H+ w' P3 `$ u
Sorafenib + temsirolimus Yes, reduced dose
, Y2 F3 [" f" O# f6 C' E9 TSorafenib + everolimus Yes, reduced dose
, r- S) c% e, O' S' uSunitinib + temsirolimus† No
$ Z+ K1 ^5 L+ T& N* F: O7 G: p4 [Sunitinib + everolimus ?
7 V( r5 X+ _! n5 ?1 t% K3 z) A" uTemsirolimus + everolimus ? " w& k; E8 Z, l
————————————————————
% h5 @" f0 T2 R H/ b$ O†Led to US FDA warning.: u2 r- ], |7 h+ N% J7 k
?: As yet unattempted combination.
$ o* T! f$ m* u5 C# U5 a |
显身卡
7 z4 S I: m) k! G0 l+ J" [8 y" D
